ArticleCancer prevention research (Philadelphia, Pa.)2020

Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer.

Deborah L Burkhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.